Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.

Part 2.1: Price Behavior Around Earnings

Cencora reports before market open, meaning Day 0 represents the first full trading session where the market reacts to results, while Day +1 captures follow-through momentum.

Historical price action reveals significant volatility around Cencora's earnings releases, with an average absolute Day 0 move of 5.71% and Day +1 move of 3.08%. The stock has shown a tendency toward positive reactions, though with notable exceptions that created substantial downside.

The most dramatic move came in May 2026, when the stock plunged -17.38% on Day 0 before recovering slightly with a +1.16% Day +1 move. This outlier significantly skews the average and highlights the potential for sharp corrections when results or guidance disappoint. In contrast, the most recent August 2026 report generated a more modest +3.57% Day 0 gain followed by a +2.46% Day +1 advance, demonstrating sustained positive momentum.

The February 2026 report showed an interesting pattern: an initial -8.79% Day 0 decline was followed by a strong +6.72% Day +1 recovery, suggesting the market sometimes needs time to digest results and reassess. The Day 0 trading range has averaged 5.82%, while Day +1 ranges average 4.26%, indicating that initial volatility tends to moderate somewhat in the following session. Investors should prepare for potential swings of 5-8% based on historical patterns, with the direction heavily dependent on whether the company meets, beats, or misses expectations on both earnings and forward guidance.

Part 2.2: Options Market Expected Move

The options market is pricing an expected move of ±7.26% ($24.74) for the November 20 expiration, which is notably higher than the stock's average historical Day 0 move of 5.71%. This suggests options traders are anticipating greater-than-typical volatility around this earnings release, possibly reflecting uncertainty around guidance or key business metrics. The implied move also exceeds the average Day 0 trading range of 5.82%, indicating the market is pricing in potential for a more significant reaction than recent history would suggest.

Part 3: What Analysts Are Saying

Analysts maintain a strongly bullish stance on Cencora, with the stock earning an average recommendation of 4.43 out of 5.0 (between Buy and Strong Buy). The consensus is heavily skewed positive, with 10 Strong Buy ratings and zero Sell or Strong Sell ratings among the 14 analysts covering the stock. Only 4 analysts rate the stock a Hold, representing less than 30% of coverage.

The average price target of $370.77 implies 8.9% upside from the current price of $340.50, with the range of estimates spanning from a low of $330.00 to a high of $400.00. The high-end target suggests some analysts see potential for 17.5% appreciation, reflecting confidence in the company's long-term growth trajectory.

Analyst sentiment has remained unchanged over the past month, with the same 10 Strong Buys, 0 Moderate Buys, 4 Holds, and 0 Sells as a month ago. This stability suggests analysts are maintaining their conviction heading into the earnings release rather than adjusting positions in anticipation. The lack of downgrades or estimate cuts in recent weeks indicates the Street is comfortable with current expectations and sees limited downside risk to the quarter. The concentration of Strong Buy ratings and the absence of any bearish calls underscore the investment community's positive view on Cencora's business model and growth prospects in pharmaceutical distribution.

Part 4: Technical Picture

Cencora enters earnings with strong technical momentum, as the Barchart Technical Opinion has surged to an 88% Buy signal, up sharply from 72% Buy last week and a dramatic reversal from the 8% Sell signal registered a month ago. This rapid improvement in technical sentiment reflects accelerating bullish momentum heading into the report.

Timeframe Analysis:

• Short-term (100% Buy): Maximum bullish signal indicates powerful near-term momentum with no technical resistance in the immediate timeframe
• Medium-term (100% Buy): Equally strong reading confirms the uptrend is well-established beyond just short-term trading, suggesting institutional accumulation
• Long-term (50% Buy): Moderate positive signal shows the longer-term trend is constructive but less emphatic, indicating some consolidation in the broader picture

Trend Characteristics: The combination of Average strength with Strongest direction suggests Cencora is in a powerful directional move that may not yet be overextended, providing a supportive backdrop for positive earnings surprises.

The stock is trading at $340.50, positioned above all key moving averages: the 5-day ($332.81), 10-day ($332.93), 20-day ($332.44), 50-day ($324.11), 100-day ($313.70), and 200-day ($316.93). This complete alignment above all moving averages is a classically bullish setup, indicating strong trend support across all timeframes.

The technical picture is decidedly supportive heading into earnings. With the stock trading above all moving averages and showing accelerating momentum across short and medium-term timeframes, Cencora has built a strong technical foundation. The 52-week range of $244.82 to $377.54 shows the current price at $340.50 sits at roughly 70% of the range, leaving room for upside toward the prior high if results exceed expectations. However, the rapid improvement in technical signals over the past month also means the stock has already priced in considerable optimism, raising the bar for a positive reaction. Any disappointment on earnings or guidance could trigger profit-taking from the recent rally, though the strong moving average support structure should provide downside cushion.